•  
  •  
  •  
  •  

2026-05-23 04:30:12

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Kolte-Patil Developers Ltd. Q4 & FY26 Financial Results
  • PNC Infratech Limited receives Rs. 228.90 crores based on settlement agreement from NHAI
  • NIS Management Ltd receives 5 work orders worth Rs. 30.77 crores
  • MAS Financial Services Ltd raises ₹360 Crore through NCD from FMO, the Dutch Entrepreneurial Development Bank
  • Aptus Pharma Ltd initiates brand promotion at Rajkot Hirasar Airport

Keywords Selected:  USFDA

Stock Report

  • Alembic Pharmaceuticals Ltd announces USFDA Final Approval for Levothyroxine Sodium Tablets USP
  • Lupin Receives U.S. FDA Approval for Famotidine Injection, USP
  • US FDA Inspection at Alkem Laboratories Ltd's CRO facility located at Taloja
  • USFDA inspection concludes at Zydus' Biologics Injectable plant, Ahmedabad
  • Caplin Steriles Ltd gets USFDA approval for Calcium Gluconate Injection
  • Lupin Receives U.S. FDA Approval for Glycerol Phenylbutyrate Oral Liquid
  • US FDA Inspection at Alkem Laboratories Ltd's manufacturing facility located at Amaliya, Daman
  • Solara announces successful closure of US FDA inspection of its Puducherry Facility with continued state of cGMP compliance
  • Alembic Pharmaceuticals Limited announces USFDA Final Approval for Fingolimod Capsules, 0.5 mg
  • USFDA inspection at Rubicon Research Ltd's R&D Facility
  • Supriya Lifescience Receives USFDA EIR with VAI Classification for Maharashtra API Facility
  • Ajanta Pharma Ltd updates on USFDA inspection
  • USFDA Inspection at Innoxel Lifesciences Private Limited
  • Orbicular's Partner secures tentative U.S. ANDA approval for a generic version of Semaglutide Injection, supported by OneSource as CDMO partner
  • USFDA inspection at Somerset facility of Lupin Ltd
  • Aurobindo Pharma receives USFDA Approval for Dextromethorphan Polistirex ExtendedRelease Oral Suspension, 30 mg/5 mL (OTC)
  • USFDA inspection at Cipla Ltd's manufacturing facility in Goa, India
  • Morepen Secures Fourth Consecutive USFDA Inspection with Zero Observations
  • Aurobindo Pharma receives USFDA Approval for Glycerol Phenylbutyrate Oral Liquid, 1.1 grams per mL
  • Zydus receives EIR for oncology injectable manufacturing facility in SEZ1, Ahmedabad
  • Alembic Pharmaceuticals Ltd announces USFDA Final Approval for Methotrexate Injection USP
  • Indoco Remedies' testing facility completes US FDA PAI
  • Glenmark Pharmaceuticals Receives U.S. FDA Approval for Progesterone Vaginal Inserts, 100 mg
  • Lupin announces approval of Dapagliflozin and Metformin Hydrochloride Extended-Release Tablets in the United States

Latest Post

  • Kolte-Patil Developers Ltd. Q4 & FY26 Financial Results
  • PNC Infratech Limited receives Rs. 228.90 crores based on settlement agreement from NHAI
  • NIS Management Ltd receives 5 work orders worth Rs. 30.77 crores
  • MAS Financial Services Ltd raises ₹360 Crore through NCD from FMO, the Dutch Entrepreneurial Development Bank
  • Aptus Pharma Ltd initiates brand promotion at Rajkot Hirasar Airport


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2025